Skip to main content

GLP-1 drugs

Industry payments by company

6 rows

CompanyPayments, 2025Clinicians paid
Novo Nordisk Inc$28.9M116,356
Lilly USA, LLC$19.1M79,338
Eli Lilly and Company$221,08766
Novo Nordisk As$45,2326
Eli Lilly Export S.a. Puerto Rico Branch$15,710262
AstraZeneca Pharmaceuticals LP$2,88749

← Back to GLP-1 drugs

Sources: CMS Medicare Part D Prescribers 2024; CMS Open Payments 2025 (general payments; a payment is not evidence of wrongdoing); FDA enforcement reports (openFDA).